Histologic Grading of Noninvasive Papillary Urothelial Neoplasms

Gregory T. MacLennan, Ziya Kirkali, Liang Cheng

Research output: Contribution to journalArticle

96 Citations (Scopus)

Abstract

Objectives: In 1998, a revised system of classifying noninvasive papillary urothelial neoplasms of the urinary bladder was proposed and subsequently formally adopted by the World Health Organization (WHO). The introduction of this new system was justified as being potentially superior on a number of levels to the 1973 WHO classification system that it replaced. Specifically, a new category of neoplasms, designated papillary urothelial neoplasm of low malignant potential (PUNLMP), was considered advantageous for several reasons. The new system was expected to gain widespread acceptance, improve reproducibility of diagnoses among pathologists, and enhance the correlation between urine cytology and tumor histology. We examine the history of the changes in terminology for these lesions, the relative merits of PUNLMP terminology, the extent to which the expectations accompanying the new grading system have been met, and the extent to which the new system has enhanced the management of patients with noninvasive papillary urothelial neoplasms of the bladder. Methods: A PubMed literature search after the introduction of this new classification was performed and relevant papers reviewed. Results and Conclusions: The 2004 WHO classification is a positive initiative in attempting to standardize urothelial tumor grading by expanding and clearly defining the morphologic characteristics of noninvasive papillary urothelial neoplasms. The new terminology used in this system is of questionable validity and utility. Full-genome searches for prognostic and predictive molecular gene expression signatures, GeneChip technology and proteomics techniques, and several new biomarkers and molecular tests may be useful in future grading schemes after their clinical utility is better established.

Original languageEnglish
Pages (from-to)889-898
Number of pages10
JournalEuropean Urology
Volume51
Issue number4
DOIs
StatePublished - Apr 2007

Fingerprint

Terminology
Neoplasms
Urinary Bladder Neoplasms
Neoplasm Grading
Transcriptome
PubMed
Proteomics
Cell Biology
Histology
Biomarkers
History
Urine
Genome
Technology

Keywords

  • Grading
  • Neoplasia
  • Papillary urothelial neoplasm of low malignant potential (PUNLMP)
  • Transitional cell carcinoma
  • Urinary bladder
  • WHO/ISUP classification

ASJC Scopus subject areas

  • Urology

Cite this

Histologic Grading of Noninvasive Papillary Urothelial Neoplasms. / MacLennan, Gregory T.; Kirkali, Ziya; Cheng, Liang.

In: European Urology, Vol. 51, No. 4, 04.2007, p. 889-898.

Research output: Contribution to journalArticle

MacLennan, Gregory T. ; Kirkali, Ziya ; Cheng, Liang. / Histologic Grading of Noninvasive Papillary Urothelial Neoplasms. In: European Urology. 2007 ; Vol. 51, No. 4. pp. 889-898.
@article{0bd14d705c1f439ba5df303a86837999,
title = "Histologic Grading of Noninvasive Papillary Urothelial Neoplasms",
abstract = "Objectives: In 1998, a revised system of classifying noninvasive papillary urothelial neoplasms of the urinary bladder was proposed and subsequently formally adopted by the World Health Organization (WHO). The introduction of this new system was justified as being potentially superior on a number of levels to the 1973 WHO classification system that it replaced. Specifically, a new category of neoplasms, designated papillary urothelial neoplasm of low malignant potential (PUNLMP), was considered advantageous for several reasons. The new system was expected to gain widespread acceptance, improve reproducibility of diagnoses among pathologists, and enhance the correlation between urine cytology and tumor histology. We examine the history of the changes in terminology for these lesions, the relative merits of PUNLMP terminology, the extent to which the expectations accompanying the new grading system have been met, and the extent to which the new system has enhanced the management of patients with noninvasive papillary urothelial neoplasms of the bladder. Methods: A PubMed literature search after the introduction of this new classification was performed and relevant papers reviewed. Results and Conclusions: The 2004 WHO classification is a positive initiative in attempting to standardize urothelial tumor grading by expanding and clearly defining the morphologic characteristics of noninvasive papillary urothelial neoplasms. The new terminology used in this system is of questionable validity and utility. Full-genome searches for prognostic and predictive molecular gene expression signatures, GeneChip technology and proteomics techniques, and several new biomarkers and molecular tests may be useful in future grading schemes after their clinical utility is better established.",
keywords = "Grading, Neoplasia, Papillary urothelial neoplasm of low malignant potential (PUNLMP), Transitional cell carcinoma, Urinary bladder, WHO/ISUP classification",
author = "MacLennan, {Gregory T.} and Ziya Kirkali and Liang Cheng",
year = "2007",
month = "4",
doi = "10.1016/j.eururo.2006.10.037",
language = "English",
volume = "51",
pages = "889--898",
journal = "European Urology",
issn = "0302-2838",
publisher = "Elsevier",
number = "4",

}

TY - JOUR

T1 - Histologic Grading of Noninvasive Papillary Urothelial Neoplasms

AU - MacLennan, Gregory T.

AU - Kirkali, Ziya

AU - Cheng, Liang

PY - 2007/4

Y1 - 2007/4

N2 - Objectives: In 1998, a revised system of classifying noninvasive papillary urothelial neoplasms of the urinary bladder was proposed and subsequently formally adopted by the World Health Organization (WHO). The introduction of this new system was justified as being potentially superior on a number of levels to the 1973 WHO classification system that it replaced. Specifically, a new category of neoplasms, designated papillary urothelial neoplasm of low malignant potential (PUNLMP), was considered advantageous for several reasons. The new system was expected to gain widespread acceptance, improve reproducibility of diagnoses among pathologists, and enhance the correlation between urine cytology and tumor histology. We examine the history of the changes in terminology for these lesions, the relative merits of PUNLMP terminology, the extent to which the expectations accompanying the new grading system have been met, and the extent to which the new system has enhanced the management of patients with noninvasive papillary urothelial neoplasms of the bladder. Methods: A PubMed literature search after the introduction of this new classification was performed and relevant papers reviewed. Results and Conclusions: The 2004 WHO classification is a positive initiative in attempting to standardize urothelial tumor grading by expanding and clearly defining the morphologic characteristics of noninvasive papillary urothelial neoplasms. The new terminology used in this system is of questionable validity and utility. Full-genome searches for prognostic and predictive molecular gene expression signatures, GeneChip technology and proteomics techniques, and several new biomarkers and molecular tests may be useful in future grading schemes after their clinical utility is better established.

AB - Objectives: In 1998, a revised system of classifying noninvasive papillary urothelial neoplasms of the urinary bladder was proposed and subsequently formally adopted by the World Health Organization (WHO). The introduction of this new system was justified as being potentially superior on a number of levels to the 1973 WHO classification system that it replaced. Specifically, a new category of neoplasms, designated papillary urothelial neoplasm of low malignant potential (PUNLMP), was considered advantageous for several reasons. The new system was expected to gain widespread acceptance, improve reproducibility of diagnoses among pathologists, and enhance the correlation between urine cytology and tumor histology. We examine the history of the changes in terminology for these lesions, the relative merits of PUNLMP terminology, the extent to which the expectations accompanying the new grading system have been met, and the extent to which the new system has enhanced the management of patients with noninvasive papillary urothelial neoplasms of the bladder. Methods: A PubMed literature search after the introduction of this new classification was performed and relevant papers reviewed. Results and Conclusions: The 2004 WHO classification is a positive initiative in attempting to standardize urothelial tumor grading by expanding and clearly defining the morphologic characteristics of noninvasive papillary urothelial neoplasms. The new terminology used in this system is of questionable validity and utility. Full-genome searches for prognostic and predictive molecular gene expression signatures, GeneChip technology and proteomics techniques, and several new biomarkers and molecular tests may be useful in future grading schemes after their clinical utility is better established.

KW - Grading

KW - Neoplasia

KW - Papillary urothelial neoplasm of low malignant potential (PUNLMP)

KW - Transitional cell carcinoma

KW - Urinary bladder

KW - WHO/ISUP classification

UR - http://www.scopus.com/inward/record.url?scp=33847095882&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33847095882&partnerID=8YFLogxK

U2 - 10.1016/j.eururo.2006.10.037

DO - 10.1016/j.eururo.2006.10.037

M3 - Article

C2 - 17095142

AN - SCOPUS:33847095882

VL - 51

SP - 889

EP - 898

JO - European Urology

JF - European Urology

SN - 0302-2838

IS - 4

ER -